NMDA hypofunction in the posterior cingulate as a model for schizophrenia: An exploratory ketamine administration study in fMRI

Georg Northoff, Andre Richter, Felix Bermpohl, Simone Grimm, Ernst Martin, Valentine Leslie Marcar, Constance Wahl, Daniel Hell, Heinz Boeker

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Based on animal data, NMDA receptor hypofunction has been suggested as a model for positive symptoms in schizophrenia. NMDA receptor hypofunction affects several corticolimbic brain regions, of which the posterior cingulate seems to be the most sensitive. However, empirical support for a crucial role of posterior cingulate NMDA hypofunction in the pathophysiology of positive symptoms is still missing in humans. We therefore conducted an fMRI study using the NMDA antagonist ketamine in healthy human subjects during episodic memory retrieval, which is supposed to activate the posterior cingulate. We investigated 16 healthy subjects which were assigned to either placebo (n=7; saline) or ketamine (n=9; 0.6 mg/kg/h) group in a double-blind study design. All subjects received their infusion while performing an episodic memory retrieval task in the scanner. Immediately after the fMRI session, psychopathological effects of ketamine were measured using the Altered States of Consciousness Questionnaire. The placebo group showed BOLD signal increases in the posterior and anterior cingulate during retrieval. Signal increases were significantly lower in the ketamine group. Lower signal increases in the posterior cingulate correlated significantly with positive (i.e. psychosis-like) symptoms induced by ketamine. The present study for the first time demonstrates a relationship between NMDA receptors, posterior cingulate and positive (i.e. psychosis-like) symptoms in humans. Confirming findings from animal studies, it supports the hypothesis of a pathophysiological role of NMDA receptor hypofunction in the posterior cingulate in schizophrenia.

Original languageEnglish
Pages (from-to)235-248
Number of pages14
JournalSchizophrenia Research
Volume72
Issue number2-3
DOIs
Publication statusPublished - Jan 1 2005

Fingerprint

Gyrus Cinguli
Ketamine
N-Methylaspartate
Schizophrenia
Magnetic Resonance Imaging
N-Methyl-D-Aspartate Receptors
Episodic Memory
Psychotic Disorders
Healthy Volunteers
Placebos
Consciousness
Double-Blind Method
Brain

Keywords

  • Episodic memory
  • fMRI
  • Ketamine
  • NMDA receptors
  • Positive symptoms
  • Posterior cingulate

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

NMDA hypofunction in the posterior cingulate as a model for schizophrenia : An exploratory ketamine administration study in fMRI. / Northoff, Georg; Richter, Andre; Bermpohl, Felix; Grimm, Simone; Martin, Ernst; Marcar, Valentine Leslie; Wahl, Constance; Hell, Daniel; Boeker, Heinz.

In: Schizophrenia Research, Vol. 72, No. 2-3, 01.01.2005, p. 235-248.

Research output: Contribution to journalArticle

Northoff, Georg ; Richter, Andre ; Bermpohl, Felix ; Grimm, Simone ; Martin, Ernst ; Marcar, Valentine Leslie ; Wahl, Constance ; Hell, Daniel ; Boeker, Heinz. / NMDA hypofunction in the posterior cingulate as a model for schizophrenia : An exploratory ketamine administration study in fMRI. In: Schizophrenia Research. 2005 ; Vol. 72, No. 2-3. pp. 235-248.
@article{9b03f61d88104e53890abf16f2423371,
title = "NMDA hypofunction in the posterior cingulate as a model for schizophrenia: An exploratory ketamine administration study in fMRI",
abstract = "Based on animal data, NMDA receptor hypofunction has been suggested as a model for positive symptoms in schizophrenia. NMDA receptor hypofunction affects several corticolimbic brain regions, of which the posterior cingulate seems to be the most sensitive. However, empirical support for a crucial role of posterior cingulate NMDA hypofunction in the pathophysiology of positive symptoms is still missing in humans. We therefore conducted an fMRI study using the NMDA antagonist ketamine in healthy human subjects during episodic memory retrieval, which is supposed to activate the posterior cingulate. We investigated 16 healthy subjects which were assigned to either placebo (n=7; saline) or ketamine (n=9; 0.6 mg/kg/h) group in a double-blind study design. All subjects received their infusion while performing an episodic memory retrieval task in the scanner. Immediately after the fMRI session, psychopathological effects of ketamine were measured using the Altered States of Consciousness Questionnaire. The placebo group showed BOLD signal increases in the posterior and anterior cingulate during retrieval. Signal increases were significantly lower in the ketamine group. Lower signal increases in the posterior cingulate correlated significantly with positive (i.e. psychosis-like) symptoms induced by ketamine. The present study for the first time demonstrates a relationship between NMDA receptors, posterior cingulate and positive (i.e. psychosis-like) symptoms in humans. Confirming findings from animal studies, it supports the hypothesis of a pathophysiological role of NMDA receptor hypofunction in the posterior cingulate in schizophrenia.",
keywords = "Episodic memory, fMRI, Ketamine, NMDA receptors, Positive symptoms, Posterior cingulate",
author = "Georg Northoff and Andre Richter and Felix Bermpohl and Simone Grimm and Ernst Martin and Marcar, {Valentine Leslie} and Constance Wahl and Daniel Hell and Heinz Boeker",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.schres.2004.04.009",
language = "English",
volume = "72",
pages = "235--248",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - NMDA hypofunction in the posterior cingulate as a model for schizophrenia

T2 - An exploratory ketamine administration study in fMRI

AU - Northoff, Georg

AU - Richter, Andre

AU - Bermpohl, Felix

AU - Grimm, Simone

AU - Martin, Ernst

AU - Marcar, Valentine Leslie

AU - Wahl, Constance

AU - Hell, Daniel

AU - Boeker, Heinz

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Based on animal data, NMDA receptor hypofunction has been suggested as a model for positive symptoms in schizophrenia. NMDA receptor hypofunction affects several corticolimbic brain regions, of which the posterior cingulate seems to be the most sensitive. However, empirical support for a crucial role of posterior cingulate NMDA hypofunction in the pathophysiology of positive symptoms is still missing in humans. We therefore conducted an fMRI study using the NMDA antagonist ketamine in healthy human subjects during episodic memory retrieval, which is supposed to activate the posterior cingulate. We investigated 16 healthy subjects which were assigned to either placebo (n=7; saline) or ketamine (n=9; 0.6 mg/kg/h) group in a double-blind study design. All subjects received their infusion while performing an episodic memory retrieval task in the scanner. Immediately after the fMRI session, psychopathological effects of ketamine were measured using the Altered States of Consciousness Questionnaire. The placebo group showed BOLD signal increases in the posterior and anterior cingulate during retrieval. Signal increases were significantly lower in the ketamine group. Lower signal increases in the posterior cingulate correlated significantly with positive (i.e. psychosis-like) symptoms induced by ketamine. The present study for the first time demonstrates a relationship between NMDA receptors, posterior cingulate and positive (i.e. psychosis-like) symptoms in humans. Confirming findings from animal studies, it supports the hypothesis of a pathophysiological role of NMDA receptor hypofunction in the posterior cingulate in schizophrenia.

AB - Based on animal data, NMDA receptor hypofunction has been suggested as a model for positive symptoms in schizophrenia. NMDA receptor hypofunction affects several corticolimbic brain regions, of which the posterior cingulate seems to be the most sensitive. However, empirical support for a crucial role of posterior cingulate NMDA hypofunction in the pathophysiology of positive symptoms is still missing in humans. We therefore conducted an fMRI study using the NMDA antagonist ketamine in healthy human subjects during episodic memory retrieval, which is supposed to activate the posterior cingulate. We investigated 16 healthy subjects which were assigned to either placebo (n=7; saline) or ketamine (n=9; 0.6 mg/kg/h) group in a double-blind study design. All subjects received their infusion while performing an episodic memory retrieval task in the scanner. Immediately after the fMRI session, psychopathological effects of ketamine were measured using the Altered States of Consciousness Questionnaire. The placebo group showed BOLD signal increases in the posterior and anterior cingulate during retrieval. Signal increases were significantly lower in the ketamine group. Lower signal increases in the posterior cingulate correlated significantly with positive (i.e. psychosis-like) symptoms induced by ketamine. The present study for the first time demonstrates a relationship between NMDA receptors, posterior cingulate and positive (i.e. psychosis-like) symptoms in humans. Confirming findings from animal studies, it supports the hypothesis of a pathophysiological role of NMDA receptor hypofunction in the posterior cingulate in schizophrenia.

KW - Episodic memory

KW - fMRI

KW - Ketamine

KW - NMDA receptors

KW - Positive symptoms

KW - Posterior cingulate

UR - http://www.scopus.com/inward/record.url?scp=9244242541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9244242541&partnerID=8YFLogxK

U2 - 10.1016/j.schres.2004.04.009

DO - 10.1016/j.schres.2004.04.009

M3 - Article

C2 - 15560968

AN - SCOPUS:9244242541

VL - 72

SP - 235

EP - 248

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 2-3

ER -